Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Dang, Nam H. ; Ogura, Michinori ; Castaigne, Sylvie ; Fayad, Luis E. ; Jerkeman, Mats LU ; Radford, John ; Pezzutto, Antonio ; Bondarenko, Igor N. ; Stewart, Douglas A. and Shnaidman, Michael , et al. (2018) In British Journal of Haematology 182(4). p.583-586
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Antibody-drug conjugate, B-cell non-Hodgkin lymphoma, CD22+, Inotuzumab ozogamicin, Rituximab
in
British Journal of Haematology
volume
182
issue
4
pages
583 - 586
publisher
Wiley-Blackwell
external identifiers
  • scopus:85021842393
  • pmid:28677896
ISSN
0007-1048
DOI
10.1111/bjh.14820
language
English
LU publication?
yes
id
03ca04e0-8db7-4914-9f9e-6bef9df5642c
date added to LUP
2017-08-18 13:35:20
date last changed
2024-03-31 14:52:43
@misc{03ca04e0-8db7-4914-9f9e-6bef9df5642c,
  author       = {{Dang, Nam H. and Ogura, Michinori and Castaigne, Sylvie and Fayad, Luis E. and Jerkeman, Mats and Radford, John and Pezzutto, Antonio and Bondarenko, Igor N. and Stewart, Douglas A. and Shnaidman, Michael and Sullivan, Sharon and Vandendries, Erik and Tobinai, Kensei and Ramchandren, Radhakrishnan and Hamlin, Paul A. and Giné, Eva and Ando, Kiyoshi}},
  issn         = {{0007-1048}},
  keywords     = {{Antibody-drug conjugate; B-cell non-Hodgkin lymphoma; CD22+; Inotuzumab ozogamicin; Rituximab}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{583--586}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{British Journal of Haematology}},
  title        = {{Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma}},
  url          = {{http://dx.doi.org/10.1111/bjh.14820}},
  doi          = {{10.1111/bjh.14820}},
  volume       = {{182}},
  year         = {{2018}},
}